DeepMed Research

JAZZ PHARMACEUTICALS FRANCE

🇫🇷France

Country: 🇫🇷France

Ownership: -

Established: 2003-01-01

Employees: -

Market Cap: -

Website: https://www.jazzpharma.com/careers/open-positions/

Clinical Trials

Study to Evaluate the Effect of Rifampicin, Ketoconazole, and Omeprazole on the Pharmacokinetics of Sativex

Phase 1

Completed

Conditions: Evaluation of Pharmacokinetics of Sativex in the Absence and Presence of a CYP2C19 Inhibitor
Evaluation of Pharmacokinetics of Sativex in the Absence and Presence of a Known Inducer of CYP3A4
Evaluation of Pharmacokinetics of Sativex in the Absence and Presence of a Potent Inhibitor of CYP3A4

Interventions: Drug: Sativex and omeprazole
Drug: Sativex and rifampicin
Drug: Sativex and ketoconazole

First Posted Date: 2011-03-25

Last Posted Date: 2023-04-10

Lead Sponsor: Jazz Pharmaceuticals

Target Recruit Count: 36

Registration Number: NCT01323465

Locations: 🇬🇧
Guy's Drug Research Unit, Quintiles Ltd., London, United Kingdom

Abuse Potential of Sativex

Phase 1

Completed

Conditions: Evaluation of Abuse Potential of Sativex

Interventions: Drug: Placebo
Drug: Marinol
Drug: Sativex

First Posted Date: 2011-03-25

Last Posted Date: 2023-04-10

Lead Sponsor: Jazz Pharmaceuticals

Target Recruit Count: 58

Registration Number: NCT01323569

Locations: 🇨🇦
DecisionLine Clinical Research Corporation, Toronto, Ontario, Canada

Study to Assess Food Effect on Sativex Bioavailability

Phase 1

Completed

Conditions: Food Effect

Interventions: Drug: Sativex

First Posted Date: 2011-03-24

Last Posted Date: 2023-04-10

Lead Sponsor: Jazz Pharmaceuticals

Target Recruit Count: 25

Registration Number: NCT01322464

Locations: 🇬🇧
Guy's Drug Research Unit, Quintiles Ltd., London, United Kingdom

Sativex Thorough QT/QTc Study

Phase 1

Completed

Conditions: Effects of Sativex on ECG

Interventions: Drug: Sativex spray and oral moxifloxacin placebo
Drug: Placebo spray and oral moxifloxacin placebo
Drug: Placebo spray and moxifloxacin

First Posted Date: 2011-03-24

Last Posted Date: 2023-04-10

Lead Sponsor: Jazz Pharmaceuticals

Target Recruit Count: 258

Registration Number: NCT01322139

Locations: 🇨🇦
DecisionLine Clinical Research Corporation, Toronto, Ontario, Canada

GWMD1092 - GWP42003 : GWP42004 Together Plus Alone in Type II Diabetes

Phase 2

Completed

Conditions: Dyslipidemias
Diabetes Mellitus, Type 2

Interventions: Drug: GWP42003
Drug: Placebo
Drug: GWP42004

First Posted Date: 2010-10-08

Last Posted Date: 2022-10-18

Lead Sponsor: Jazz Pharmaceuticals

Target Recruit Count: 62

Registration Number: NCT01217112

Locations: 🇬🇧
University of Nottingham, Medical School at Derby, Royal Derby Hospital, Derby, United Kingdom
🇬🇧
Mount Farm Surgery, Bury Saint Edmonds, United Kingdom
🇬🇧
MAC UK Neuroscience Ltd., Manchester, United Kingdom

and more 2 locations

Caphosol for the Reduction of Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer

Phase 1

Conditions: Oral Mucositis

First Posted Date: 2009-05-14

Last Posted Date: 2009-05-14

Lead Sponsor: Jazz Pharmaceuticals

Target Recruit Count: 100

Registration Number: NCT00901732

Locations: 🇺🇸
University of Florida College of Medicine, Gainesville, Florida, United States
🇺🇸
Beth Israel Medical Center, New York, New York, United States
🇺🇸
H. Lee Moffitt Cancer Center, Tampa, Florida, United States

and more 3 locations

Trial of CPX-351 in Adult Patients With First Relapse Acute Myeloid Leukemia (AML)

Phase 2

Completed

Conditions: Acute Myeloid Leukemia

Interventions: Drug: CPX-351
Drug: Intensive Salvage Therapy

First Posted Date: 2009-01-14

Last Posted Date: 2017-11-24

Lead Sponsor: Jazz Pharmaceuticals

Target Recruit Count: 126

Registration Number: NCT00822094

Locations: 🇺🇸
UTMB Comprehensive Cancer Center, Galveston, Texas, United States
🇺🇸
St. Francis Cancer Center, Beech Grove, Indiana, United States
🇨🇦
Cancer Care Manitoba, Winnipeg, Manitoba, Canada

and more 39 locations

Safety and Tolerability Study Comparing Sodium Oxybate Given as an Oral Solution to a Single-blinded Combination of Oral Tablets Plus Oral Solution in Subjects With Fibromyalgia

Phase 3

Completed

Conditions: Fibromyalgia

Interventions: Drug: Sodium Oxybate
Drug: Sodium Oxybate & 6 Tablets
Drug: Sodium Oxybate Oral Solution (6 grams)
Drug: Sodium Oxybate & 8 Tablets

First Posted Date: 2008-12-05

Last Posted Date: 2011-08-19

Lead Sponsor: Jazz Pharmaceuticals

Target Recruit Count: 129

Registration Number: NCT00803023

Locations: 🇺🇸
Sun Research Institute, San Antonio, Texas, United States
🇺🇸
Arizona Research Center, Phoenix, Arizona, United States
🇺🇸
Dba 21st Century Neurology, Phoenix, Arizona, United States

and more 29 locations

Trial of CPX-351 in Newly Diagnosed Elderly AML Patients

Phase 2

Completed

Conditions: Acute Myeloid Leukemia

Interventions: Drug: CPX-351
Drug: Cytarabine
Drug: Daunorubicin

First Posted Date: 2008-11-11

Last Posted Date: 2018-01-12

Lead Sponsor: Jazz Pharmaceuticals

Target Recruit Count: 126

Registration Number: NCT00788892

Locations: 🇺🇸
Cedars Sinai Medical Center, Los Angeles, California, United States
🇺🇸
North Shore University Hospital, Manhasset, New York, United States
🇺🇸
Arizona Cancer Center, Tucson, Arizona, United States

and more 25 locations

A Study to Determine the Maintenance of Effect After Long-term Treatment of Sativex® in Subjects With Neuropathic Pain

Phase 3

Completed

Conditions: Pain
Peripheral Neuropathy

Interventions: Drug: Sativex®
Drug: Placebo

First Posted Date: 2008-07-11

Last Posted Date: 2023-05-03

Lead Sponsor: Jazz Pharmaceuticals

Target Recruit Count: 19

Registration Number: NCT00713817

Locations: 🇬🇧
Pain Management Research, Clinical Trials Unit, Netherwood House, Solihull Hospital, Solihull, West Midlands, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy